ABEO - アビオナ・セラピュ―ティクス （Abeona Therapeutics Inc.）

Abeona Therapeutics press release (ABEO): FY GAAP EPS of -$5.53 misses by $1.61.Revenue of $1.41M (-53.0% Y/Y) misses by $0.91M.Cash, cash equivalents, restricted cash and…

Expects to submit BLA for EB-101 to FDA in late-2Q/early-3Q 2023 based on positive Phase 3 VIITAL™ study results announced in 4Q 2022

Continue reading on Medium »

NEW YORK and CLEVELAND, March 24, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new employees who joined Abeona. On March 23, 2023, Abeona granted restricted stock equity awards to six employees as an inducement for them to accept employment, which equity awards relate to, in the aggregate, up to 131,750 restricted shares of Abeona

NEW YORK and CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that additional data from its pivotal Phase 3 VIITAL study of EB-101 for recessive dystrophic epidermolysis bullosa (RDEB) has been accepted for an oral presentation at the inaugural International Societies for Investigative Dermatology (ISID) Meeting, being held May 10-13, 2023 in

Gianers: Hempacco Co HPCO +36%.Happiness Development Group (HAPP) +33%.Applied DNA Sciences APDN +29%.Pineapple Energy PEGY +26%.Gatos Silver GATO +24%.Greenwave Technology Solutions…

The Chronic Wounds market is expected to surge due to the disease''s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics. DelveInsight''s "Chronic Wounds

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY ) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday. Inventiva S.A. (NASDAQ: IVA ) climbed 69.5% to settle at $7.05 after gaining around 10% on Thursday. Minim, Inc. (NASDAQ: MINM ) rose 50.9% to close at $0.32 on Friday. Minim, during August, posted a Q2 loss of $0.10 per share. New Concept Energy, Inc. (NYSE: GBR ) gained 30% to close at $1.56. Abeona Therapeutics Inc. (NASDAQ: ABEO ) climbed 25.3% to close at $4.41. Abeona Therapeutics recently announced completion of patient follow-up in pivotal Phase 3 VIITAL study of EB-101. Aehr Test Systems (NASDAQ: AEHR ) climbed 23.9% to close at $17.19 after the company announced better-than-expected Q1 EPS and sales results and issued guidance. Brookdale Senior Living Inc. (NYSE: BKD ) gained 20% to close at $4.81. Brookdale Senior Living is said to explore a sale, Bloomberg reported. Ambac Financial Group, Inc (NASDAQ: AMBC ) climbed 15.6% to close at $14.80 after the company announced it settled its RMBS litigations against Bank of America for $1.84 billion. eMagin Corporation (NYSE: EMAN ) rose 15.6% to close at $0.7170. eMagin, in August, reported second-quarter FY22 revenue growth of 14% year-on-year to $7.2 million.

Gainers: Innovative Eyewear LUCY +98%.Green Giant (GGE) +34%.Top Ships TOPS +29%.Inventiva S.A

A share of Abeona Therapeutics Inc. (NASDAQ:ABEO) closed at $3.21 per share on Wednesday, down from $3.41 day before. While Abeona Therapeutics Inc. has underperformed by -5.87%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ABEO fell by -86.49%, with highs and lows ranging from $26.75 […]

Abeona Therapeutics Inc. (NASDAQ:ABEO) has a beta value of 1.33 and has seen 2.81 million shares traded in the last trading session. The company, currently valued at $29.69M, closed the last trade at $0.18 per share which meant it lost $0.0 on the day or 0.60% during that session. The ABEO stock price is -866.67% … Abeona Therapeutics Inc. (ABEO) Gain 0.60%, Marking Win By Bears Read More »

During the last session, Abeona Therapeutics Inc. (NASDAQ:ABEO)’s traded shares were 2.57 million, with the beta value of the company hitting 1.39. At the end of the trading day, the stock’s price was $0.19, reflecting an intraday gain of 8.11% or $0.02. The 52-week high for the ABEO share is $1.75, that puts it down … Abeona Therapeutics Inc. (NASDAQ: ABEO) Surged 19.30% In 6 Months – Here’s What To Expect Next Read More »

Abeona Therapeutics Inc. (NASDAQ:ABEO)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.48. At the close of trading, the stock’s price was $0.16, to imply a decrease of -3.40% or $0.0 in intraday trading. The ABEO share’s 52-week high remains $1.77, putting it -1006.25% down since that … Abeona Therapeutics Inc. (NASDAQ: ABEO) Has Decreased By -90.87 Percent This Year. Is It A Better Buy Than Others? Read More »

Full and original release on www.actusnews.com . Subscribe to this company''s information.

Full and original release on www.actusnews.com . Subscribe to this company''s information.